IGFBP-3 mediates TGF-beta1-induced cell growth in human airway smooth muscle cells.

Both insulin-like growth factor binding protein-3 (IGFBP-3) and transforming growth factor-beta (TGF-beta) have been separately shown to have cell-specific growth-inhibiting or growth-potentiating effects. TGF-beta stimulates IGFBP-3 mRNA and peptide expression in several cell types, and TGF-beta-induced growth inhibition and apoptosis have been shown to be mediated through the induction of IGFBP-3. However, a link between the growth stimulatory effects of TGF-beta and IGFBP-3-induction has not been shown. In this study, we investigated the role of IGFBP-3 in mediating TGF-beta1-induced cell growth using human airway smooth muscle (ASM) cells as our model. TGF-beta1 (1 ng/ml) treatment induced a 10- to 20-fold increase in the levels of expression of IGFBP-3 mRNA and protein. Addition of either IGFBP-3 or TGF-beta1 to the growth medium resulted in an approximately twofold increase in cell proliferation. Coincubation of ASM cells with IGFBP-3 antisense (but not sense) oligomers as well as with an IGFBP-3 neutralizing antibody (but not with control IgG) blocked the growth induced by TGF-beta1 (P < 0.001). Several IGFBP-3-associated proteins were observed in ASM cell lysates, which may have a role in the cellular responses to IGFBP-3. These findings demonstrate that IGFBP-3 is capable of mediating the growth stimulatory effect of TGF-beta in ASM cells.

[1]  H. S. Sharma,et al.  Angiotensin II Induces Hypertrophy of Human Airway Smooth Muscle Cells : Expression of Transcription Factors and Transforming Growth Factor-b 1 , 1998 .

[2]  R. Martin,et al.  Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. , 1997, American journal of respiratory cell and molecular biology.

[3]  S. Leal,et al.  The Type V Transforming Growth Factor β Receptor Is the Putative Insulin-like Growth Factor-binding Protein 3 Receptor* , 1997, The Journal of Biological Chemistry.

[4]  P. Howarth,et al.  Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. , 1997, American journal of respiratory and critical care medicine.

[5]  J. J. Sando,et al.  Deficient Tyrosine Phosphorylation of c-Cbl and Associated Proteins in Phorbol Ester-resistant EL4 Mouse Thymoma Cells* , 1997, The Journal of Biological Chemistry.

[6]  P. Cohen,et al.  Insulin-like Growth Factor (IGF)-binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-β1 on Programmed Cell Death through a p53- and IGF-independent Mechanism* , 1997, The Journal of Biological Chemistry.

[7]  M. Cohen,et al.  TGF-beta 1 modulates human airway smooth-muscle cell proliferation induced by mitogens. , 1997, American journal of respiratory cell and molecular biology.

[8]  P. Black,et al.  Response of airway smooth muscle cells to TGF-beta 1: effects on growth and synthesis of glycosaminoglycans. , 1996, The American journal of physiology.

[9]  P. Cohen,et al.  Leukotriene D4 induces MMP-1, which functions as an IGFBP protease in human airway smooth muscle cells. , 1996, The American journal of physiology.

[10]  Z. Gucev,et al.  Insulin-like Growth Factor Binding Protein 3 Mediates Retinoic Acid- and Transforming Growth Factor β2-induced Growth Inhibition in Human Breast Cancer Cells , 1996 .

[11]  M. Binoux,et al.  Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3). , 1995, Endocrinology.

[12]  R. Rosenfeld,et al.  Transforming Growth Factor- β-induced Cell Growth Inhibition in Human Breast Cancer Cells Is Mediated through Insulin-like Growth Factor-binding Protein-3 Action (*) , 1995, The Journal of Biological Chemistry.

[13]  P. Cohen,et al.  The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. , 1995, Molecular endocrinology.

[14]  D. Clemmons,et al.  Insulin-like growth factors and their binding proteins: biological actions. , 1995, Endocrine reviews.

[15]  D. Peehl,et al.  Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. , 1994, The Journal of endocrinology.

[16]  Y. Oh,et al.  Insulin‐like growth factor binding proteins and their regulation , 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[17]  S. S. Huang,et al.  Kinase activity of the type V transforming growth factor beta receptor. , 1994, The Journal of biological chemistry.

[18]  R. Rosenfeld,et al.  Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. , 1993, The Journal of biological chemistry.

[19]  L. Giudice,et al.  Insulin-like growth factor (IGF), IGF binding protein (IGFBP), and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata. , 1993, Human reproduction.

[20]  O. Cussenot,et al.  IGF binding protein-3 secreted by the prostate adenocarcinoma cells (PC-3): differential effect on PC-3 and normal prostate cell growth. , 1993, Growth regulation.

[21]  R. Rosenfeld,et al.  Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. , 1993, The Journal of biological chemistry.

[22]  R. Thweatt,et al.  Insulin-like growth factor binding protein-3 is overexpressed in senescent and quiescent human fibroblasts , 1993, Experimental Gerontology.

[23]  S. S. Huang,et al.  Transforming growth factor beta (TGF-beta) type V receptor has a TGF-beta-stimulated serine/threonine-specific autophosphorylation activity. , 1992, The Journal of biological chemistry.

[24]  R. Baxter,et al.  Insulin-like growth factor-I (IGF-I) and transforming growth factor-beta 1 release IGF-binding protein-3 from human fibroblasts by different mechanisms. , 1992, Endocrinology.

[25]  G. Gibbons,et al.  Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. , 1992, The Journal of clinical investigation.

[26]  H. Moses,et al.  TGF‐β regulation of epithelial cell proliferation , 1992, Molecular reproduction and development.

[27]  C. Conover,et al.  Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. , 1992, Endocrinology.

[28]  C. Conover,et al.  Glycosylation of insulin-like growth factor binding protein-3 (IGFBP-3) is not required for potentiation of IGF-I action: evidence for processing of cell-bound IGFBP-3. , 1991, Endocrinology.

[29]  S. Goldstein,et al.  Insulin-like growth factor binding protein 3 accumulates to high levels in culture medium of senescent and quiescent human fibroblasts. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[30]  D. Clemmons,et al.  Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. S. Huang,et al.  Expression of a new type high molecular weight receptor (type V receptor) of transforming growth factor beta in normal and transformed cells. , 1991, Biochemical and biophysical research communications.